Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.59 |
| ▸ | BCL9 | O00512 | 1/20 | 0.57 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | MGLL | Q99685 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.48 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.48 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10062010 | 0.95 | HTR2A (0.56) | HTR2ABCL9CTNNB1GAAPKM | |
| SCHEMBL125510 | 0.95 | HTR2A (0.56) | HTR2ABCL9CTNNB1GAAPKM | |
| SCHEMBL763025 | 0.93 | HTR2A (0.57) | HTR2ABCL9CTNNB1GAAPKM | |
| SCHEMBL9223114 | 0.92 | HTR2A (0.60) | HTR2ABCL9CTNNB1GAAPKM | |
| SCHEMBL14495241 | 0.92 | HTR2A (0.53) | HTR2ABCL9CTNNB1GAAPKM | |
| SCHEMBL409084 | 0.92 | HTR2A (0.56) | HTR2ABCL9CTNNB1GAAPKM | |
| SCHEMBL4433836 | 0.92 | HTR2A (0.56) | HTR2ABCL9CTNNB1GAAPKM | |
| SCHEMBL13320017 | 0.92 | BCL9 (0.54) | HTR2ABCL9CTNNB1GAAPKM | |
| SCHEMBL22959846 | 0.92 | HTR2A (0.56) | HTR2ABCL9CTNNB1GAAPKM | |
| SCHEMBL1133822 | 0.92 | HTR2A (0.56) | HTR2ABCL9CTNNB1GAAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024010867-A1 | REVERSIBLE, COVALENT POLYNUCLEOTIDE CONDENSATION APPROACH FOR ENHANCED GENE DELIVERY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-01-11 | — | — | WO | claimed |
| US-20210308323-A1 | COMPOSITION AND KITS FOR PSEUDOPLASTIC MICROGEL MATRICES | ROCHAL INDUSTRIES, LLC (US) | 2021-10-07 | — | — | US | claimed |
| EP-3283057-B1 | COMPOSITION AND KITS FOR PSEUDOPLASTIC MICROGEL MATRICES | ROCHAL IND LLC (US) | 2021-07-28 | — | — | EP | claimed |
| EP-3283057-A1 | COMPOSITION AND KITS FOR PSEUDOPLASTIC MICROGEL MATRICES | Rochal Industries, LLC (US) | 2018-02-21 | — | — | EP | claimed |
| WO-2016168196-A1 | COMPOSITION AND KITS FOR PSEUDOPLASTIC MICROGEL MATRICES | ROCHAL INDUSTRIES, LLC (US) | 2016-10-20 | — | — | WO | claimed |
| US-20160303281-A1 | COMPOSITION AND KITS FOR PSEUDOPLASTIC MICROGEL MATRICES | ROCHAL INDUSTRIES, LLC (US) | 2016-10-20 | — | — | US | claimed |
| US-12018122-B2 | Method for producing silane-modified polymers | MERZ+BENTELI AG (CH) | 2024-06-25 | — | — | US | disclosed |
| WO-2024010867-A1 | REVERSIBLE, COVALENT POLYNUCLEOTIDE CONDENSATION APPROACH FOR ENHANCED GENE DELIVERY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-01-11 | — | — | WO | disclosed |
| US-11590259-B2 | Composition and kits for pseudoplastic microgel matrices | ROCHAL TECHNOLOGIES LLC (US) | 2023-02-28 | — | — | US | disclosed |
| US-20210308323-A1 | COMPOSITION AND KITS FOR PSEUDOPLASTIC MICROGEL MATRICES | ROCHAL INDUSTRIES, LLC (US) | 2021-10-07 | — | — | US | disclosed |
| EP-3283057-B1 | COMPOSITION AND KITS FOR PSEUDOPLASTIC MICROGEL MATRICES | ROCHAL IND LLC (US) | 2021-07-28 | — | — | EP | disclosed |
| US-20160303281-A1 | COMPOSITION AND KITS FOR PSEUDOPLASTIC MICROGEL MATRICES | ROCHAL INDUSTRIES, LLC (US) | 2016-10-20 | — | — | US | disclosed |
| US-20120064061-A1 | ADHESIVE COMPOSITION COMPRISING TANNIN, POLY(ETHYLENE GLYCOL), AND WATER, LOWER ALCOHOL OR MIXTURE THEREOF | INNOTHERAPY INC. (KR) | 2012-03-15 | — | — | US | disclosed |
| US-7662908-B2 | Process for the preparation of activated polythylene glycols | RBA PHARMA INC. (CA) | 2010-02-16 | — | — | US | disclosed |
| US-20080317810-A1 | Methods and Compositions for Reducing Oxalate Concentrations | OXTHERA, INC. | 2008-12-25 | — | — | US | disclosed |
| US-20080139854-A1 | Process for the preparation of activated polyethylene glycols | RBA PHARMA INC. (CA) | 2008-06-12 | — | — | US | disclosed |
| US-7351787-B2 | Process for the preparation of activated polyethylene glycols | BIOARTIFICIAL GEL TECHNOLOGIES, INC. (CA) | 2008-04-01 | — | — | US | disclosed |
| EP-1755655-A2 | METHODS AND COMPOSITIONS FOR REDUCING OXALATE CONCENTRATIONS | OxThera, Inc., (US) | 2007-02-28 | — | — | EP | disclosed |
| US-20070039874-A1 | Membranes and methods of treating membranes | GENERAL ELECTRIC COMPANY | 2007-02-22 | — | — | US | disclosed |
| WO-2005110469-A2 | METHODS AND COMPOSITIONS FOR REDUCING OXALATE CONCENTRATIONS | OXTHERA, INC. (US) | 2005-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120064061-A1 | ADHESIVE COMPOSITION COMPRISING TANNIN, POLY(ETHYLENE GLYCOL), AND WATER, LOWER ALCOHOL OR MIXTURE THEREOF | EPCAM, ICAM1, VCAM1 | HTR2A 2734/4885BCL9 2620/4885CTNNB1 3530/4885 |
| US-20080139854-A1 | Process for the preparation of activated polyethylene glycols | POLI, PMAIP1, PARG | HTR2A 2498/4885BCL9 3781/4885CTNNB1 4280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.